NCT07177209View on ClinicalTrials.gov

Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population

Not yet recruitingOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

September 8, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Ulcerative Colitis
Interventions
DRUG

Non-Interventional Study

As provided in real world practice

Trial Locations (1)

KT20 7NS

Pfizer, Walton Oaks

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT07177209 - Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population | Biotech Hunter | Biotech Hunter